EMA — authorised 27 May 2023
- Marketing authorisation holder: ROCHE REGISTRATION GMBH
- Status: approved
EMA authorised Fuzeon on 27 May 2023
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 27 May 2023.
ROCHE REGISTRATION GMBH holds the EU marketing authorisation.